| Investor Type | Firm |
| Type of Fund | VC |
| Stages | Early Stage, Seed |
Panacea Stars is a UK-based venture capital firm dedicated to challenging perceptions, transforming innovations, and changing lives by collaborating with groundbreaking sci-entrepreneurs. Specializing in early-stage and seed investments, they aim to develop successful life sciences and healthcare ventures.
Recognizing the technical challenges, high costs, and unpredictability of building ventures in these sectors, their approach involves de-risking projects and fast-tracking development. They provide a multi-phase framework from concept to market that includes non-dilutive translational funding, equity investment packages, commercialization services, and business development support.
Additionally, they offer design, development, and prototyping of scientific proofs-of-concept, executive mentorship, and access to a global network, alongside lab and office space.
They celebrate having supported over 300 startups, with 20% securing over £500k in seed investments, and a combined value of the top 55 ventures being approximately £1 billion.
Panacea Stars has a story of successful partnership stories and mentoring that has seen an impressive track record of acquisitions and funding rounds for its portfolio companies. Examples include DJS Antibodies, Enterobiotix, Phenomic AI, Mytos (Cytera CellWorks), Feebris, VisusNano Ltd., Cambridge Cancer Genomics, and SAVA Health (Caura).
They have worked with partners like Innovate UK, AstraZeneca, J A Kemp, KPMG, and Becton Dickinson Technology & Innovation to support sci-entrepreneurs in translating their scientific ideas into successful commercial ventures.








